 |
YOCON's Umbilical Cord Mesenchymal Stem Cell Serum-Free Medium represents a significant leap forward in cell culture technology. Designed with the demanding needs of stem cell research and therapeutic applications in mind, this medium provides an optimal, defined environment for MSC proliferation. Its unique formulation eliminates the variability and safety concerns associated with serum-containing media, offering a consistent and reliable solution for high-quality MSC production. Our dedication to innovation and quality ensures that researchers and developers can achieve reproducible and clinically relevant outcomes.
Property | Detail |
Product Name | Umbilical Cord Mesenchymal Stem Cell Serum-Free Medium |
Primary Use | Primary isolation and expansion of MSCs from various tissue sources |
Components | Pure factor system, completely serum-free |
Animal-Derived | Free |
Human-Derived | Free |
Regulatory Status | US FDA Class II Medical Device Registration (510(K): K232543) |
Yield (Umbilical Cord) | >2.4 x 10⁷ cells from 20 cm normal umbilical cord (primary isolation) |
Passage Stability | Maintains stable cell characteristics up to P20 |
True Serum-Free Formulation: Eliminates the need for animal serum, minimizing lot-to-lot variability and reducing the risk of contamination from animal-derived pathogens.
High Proliferation Capacity: Supports rapid and efficient expansion of MSCs, yielding a large number of high-quality cells.
Maintained Cell Characteristics: Ensures that MSCs retain their essential characteristics, including morphology, immunophenotype, and multipotent differentiation capabilities through extended passages.
Biocompatibility and Safety Tested: Rigorously tested for biocompatibility and toxicity to ensure the highest safety profile for cellular applications.
Regulatory Support: US FDA 510(K) clearance simplifies the regulatory pathway for downstream drug applications.
Data of Continuous Subculturing
*The above data was obtained from serum-free medium and stem cell mild digestive enzymes by Yocon Biology primary separation technique. Different umbilical cord samples and different separation techniques may lead to significant differences in results.
Enhanced Research Reliability: Achieve more consistent and reproducible results due to the defined and serum-free nature of the medium, reducing experimental variability.
Accelerated Development: The high cell yield and rapid expansion capabilities shorten the time required for research and development cycles.
Superior Safety Profile: Eliminate concerns about xeno-contamination, making this medium ideal for clinical and therapeutic applications where product safety is paramount.
Primary Isolation of MSCs: Optimized for the initial isolation of mesenchymal stem cells from various human tissues including umbilical cord, adipose tissue, bone marrow, and more.
Large-Scale MSC Expansion: Ideal for expanding MSC populations for research, clinical trials, and therapeutic manufacturing.
Stem Cell Research: Supports studies on MSC biology, differentiation, and regenerative medicine.
Drug Discovery and Development: Provides a reliable platform for high-throughput screening and development of cell-based therapies.
YOCON's Umbilical Cord Mesenchymal Stem Cell Serum-Free Medium represents a significant leap forward in cell culture technology. Designed with the demanding needs of stem cell research and therapeutic applications in mind, this medium provides an optimal, defined environment for MSC proliferation. Its unique formulation eliminates the variability and safety concerns associated with serum-containing media, offering a consistent and reliable solution for high-quality MSC production. Our dedication to innovation and quality ensures that researchers and developers can achieve reproducible and clinically relevant outcomes.
Property | Detail |
Product Name | Umbilical Cord Mesenchymal Stem Cell Serum-Free Medium |
Primary Use | Primary isolation and expansion of MSCs from various tissue sources |
Components | Pure factor system, completely serum-free |
Animal-Derived | Free |
Human-Derived | Free |
Regulatory Status | US FDA Class II Medical Device Registration (510(K): K232543) |
Yield (Umbilical Cord) | >2.4 x 10⁷ cells from 20 cm normal umbilical cord (primary isolation) |
Passage Stability | Maintains stable cell characteristics up to P20 |
True Serum-Free Formulation: Eliminates the need for animal serum, minimizing lot-to-lot variability and reducing the risk of contamination from animal-derived pathogens.
High Proliferation Capacity: Supports rapid and efficient expansion of MSCs, yielding a large number of high-quality cells.
Maintained Cell Characteristics: Ensures that MSCs retain their essential characteristics, including morphology, immunophenotype, and multipotent differentiation capabilities through extended passages.
Biocompatibility and Safety Tested: Rigorously tested for biocompatibility and toxicity to ensure the highest safety profile for cellular applications.
Regulatory Support: US FDA 510(K) clearance simplifies the regulatory pathway for downstream drug applications.
Data of Continuous Subculturing
*The above data was obtained from serum-free medium and stem cell mild digestive enzymes by Yocon Biology primary separation technique. Different umbilical cord samples and different separation techniques may lead to significant differences in results.
Enhanced Research Reliability: Achieve more consistent and reproducible results due to the defined and serum-free nature of the medium, reducing experimental variability.
Accelerated Development: The high cell yield and rapid expansion capabilities shorten the time required for research and development cycles.
Superior Safety Profile: Eliminate concerns about xeno-contamination, making this medium ideal for clinical and therapeutic applications where product safety is paramount.
Primary Isolation of MSCs: Optimized for the initial isolation of mesenchymal stem cells from various human tissues including umbilical cord, adipose tissue, bone marrow, and more.
Large-Scale MSC Expansion: Ideal for expanding MSC populations for research, clinical trials, and therapeutic manufacturing.
Stem Cell Research: Supports studies on MSC biology, differentiation, and regenerative medicine.
Drug Discovery and Development: Provides a reliable platform for high-throughput screening and development of cell-based therapies.
